Search for: "Sanofi GmbH"
Results 41 - 60
of 72
Sorted by Relevance
|
Sort by Date
2 Feb 2011, 3:52 am
Meda Pharma GmbH & Co. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
2 Nov 2022, 11:43 am
Abitron Austria GmbH v. [read post]
23 Apr 2024, 10:28 am
Sanofi. [read post]
6 Apr 2015, 2:37 pm
This was not to be.Plaintiff Debra Johnson was one of fifty-two plaintiffs born in the late 1950’s or early 1960’s who filed state-court Thalidomide suits in Philadelphia against GlaxoSmithKline and certain of its affiliates (“GSK”), along with Sanofi-Aventis and/or Grunenthal GmbH. [read post]
15 Jul 2023, 6:00 am
DeJoy A 600/1 54 6/29/23 21-1043 Abitron Austria GmbH v. [read post]
15 Jul 2023, 6:00 am
DeJoy A 600/1 54 6/29/23 21-1043 Abitron Austria GmbH v. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
11 Oct 2011, 3:12 am
Yesterday the IPKat celebrated the fact that two extra days were given to anyone who wants to advise the UK government whether -- and how -- to intervene in Case C-414/11 Daiichi Sankyo Company Limited, Sanofi-Aventis Deutschland GmbH v DEMO Anonimos Viomikhaniki kai Emporiki Etairia Farmakon , a Greek reference for a preliminary ruling by the Court of Justice of the European Union on some TRIPS-related issues (see his earlier post here). [read post]
7 Oct 2011, 7:16 am
It's Case C-414/11 Daiichi Sankyo Company Limited, Sanofi-Aventis Deutschland GmbH v DEMO Anonimos Viomikhaniki kai Emporiki Etairia Farmakon and it comes all the way from the Polimeles Protodikio Athinon (Greece). [read post]
1 Dec 2009, 9:45 am
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
19 Oct 2011, 3:30 am
: Daiichi Sankyo Company Limited, Sanofi-Aventis Deutschland GmbH v DEMO Anonimos Viomikhaniki kai Emporiki Etairia Farmakon (IPKat) (The SPC Blog) Naprelan (Naproxen) – US: Lawsuit seeks to compel FDA compliance with PDUFA user fee waiver provisions: Stat-Trade v USFDA (FDA Law Blog) OxyContin(Oxycodone) – US: Purdue Pharma files patent infringement complaint against Ranbaxy in response to Para IV certification filing (Patent Docs) Plavix (Clopidogrel) – US:… [read post]
3 Jan 2019, 5:21 am
C00716606/01 (for the active ingredient sevelamer) and their exclusive licensee Sanofi-Aventis (Suisse) SA enforced their SPC against Swiss pharmaceutical company Salmon Pharma GmbH which had started marketing a generic version of Sanofi-Aventis’ medicament Renvela® containing the active ingredient sevelamer carbonate. [read post]
22 Feb 2012, 7:37 am
GmbH and Sanofi-aventis v. [read post]
16 Jan 2009, 7:00 am
(IP Dragon) Patent strategies for foreign R&D work in China (Philip Brooks' Patent Infringement Updates) All clichés but still true: Intellectual Property Rights enforcement in China leaves room for improvement (IP Dragon) Recognition and protection of well-known trade marks (International Law Office) Revised Chinese patent law aims at quality, compulsory licensing (Intellectual Property Watch) Zen and the art of intellectual property in China (IP Dragon) Colombia… [read post]
31 Jan 2023, 2:59 pm
Abitron Austria GMBH v. [read post]
30 Nov 2009, 12:00 am
Stichting de Thuiskopie v Opus Supplies Deutschland GmbH(The 1709 Copyright Blog) ECJ: upholds ‘compulsory licences’ of Green Dot trade mark: Der Grüne Punkt-Duales System Deutschland GmbH v European Commission (JIPLP) ECJ: Manifest inadmissibility of reference for preliminary ruling in Canon Kabushiki Kaisha (C-181/09) (Class 46) (IPKat) Bud court asks ECJ: what is ‘acquiesced’? [read post]
25 Jan 2017, 11:25 pm
In referring the question on Art 3(a) as to what was required for a product to be protected by a basic patent, he stated that he was “encouraged by what the [CJEU] said in Actavis v Sanofi and Actavis v Boehringer to believe that there is a realistic prospect of the Court providing further and better guidance to that which it has hitherto provided” (para 91). [read post]
22 Feb 2008, 6:00 pm
: (Securing Innovation),IP in unconventional industries: (Cairns)Global - Trade Marks / Domain Names / BrandsICANN panel questions Network Solutions on domain name frontrunning: (Ars Technica), (Out-Law),ICANN: New TLD’s policy: (Class 46), ICANN not yet ready to sever ties to US government: (IP Justice), Comments to the US government on review of joint project agreement with ICANN: (IP Justice), Domain names are bigger than trade marks: ICANN’s new consumer protection role:… [read post]
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
